<?xml version="1.0" encoding="UTF-8"?>
<p id="Par26">National Center for Advancing Translational Sciences (NCATS) and Acer Therapeutics (pharmaceutical company) have agreed on placebo-controlled and random tests of this antiviral drug on COVID-19 patients.</p>
